Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 3 | 2 | 16 | 17 |
| Average estimate | 79.72 | 59.84 | 266.65 | 321.35 |
| Low estimate | 74.23 | 57.27 | 234 | 267.80 |
| High estimate | 89.32 | 62.41 | 292.33 | 367.92 |
| Last year EPS | 165.80 | 51.61 | 359.56 | 266.65 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 5 | 5 | 13 | 19 |
| Avg. estimate | 12.44T | 12.90T | 50.16T | 51.84T |
| Low estimate | 11.24T | 12.15T | 49T | 50.05T |
| High estimate | 13.03T | 14.38T | 51.10T | 54.10T |
| Last year sales | 12.39T | 12.36T | 18.28T | 50.16T |
| Sales growth | 0 | 0.04 | 1.74 | 0.03 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 79.72 | 59.84 | 266.65 | 321.35 |
| 7 days ago | 73.39 | 63.31 | 263.53 | 319.14 |
| 30 days ago | 68.62 | 65.38 | 258.59 | 307.17 |
| 60 days ago | 64.59 | 61.21 | 248.56 | 299.05 |
| 90 days ago | 70.76 | 66.59 | 241.89 | 296.10 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 2 | 1 | 1 | 1 |
| Up last 30 days | 2 | 1 | 5 | 6 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 0 | 0 | 1 | 0 |
Recommendation
Buy